Glioblastoma is a devastating disease, and the need for better treatments is unquestionable. But none of the issues being discussed here are created by posters. Message-board commentary does not determine or hinder approvals, filings, or outcomes. Those decisions rest entirely with the company. If there are concerns about delays, regulatory strategy, or progress, they ultimately belong with NWBO’s management — not with people asking questions or raising concerns.